Validation of cognitive complaints appears to improve mood in patients with persistent chemotherapy-cognitive impairment, Vanderbilt researchers report.

Leah Jesse, MD, a Psychiatry resident, successfully brought an anti-stigma resolution to the floor of the Tennessee Medical Association (TMA) House of Delegates meeting in May.

For people with co-occurring mental health disorders and substance use disorders, finding integrated care that treats both conditions can be a difficult task. Vanderbilt Behavioral Health is seeking to simplify care for these patients through the co-occurring disorders intensive outpatient program (IOP).

Older adults with depression face a unique obstacle — dealing with both a mental illness and the challenges that come along with aging. Currently, there are no treatments on the market targeting depression in this specific group.

Kristopher Kast, MD, assistant professor in the Department of Psychiatry and Behavioral Sciences and clinical director of Vanderbilt’s Addiction Consult Service, has discovered a strong association between attention-deficit/hyperactivity disorder (ADHD) pharmacotherapy and retention rates for substance use disorder (SUD) treatment.

Aaron Brinen, PsyD, has joined Vanderbilt University Medical Center from Drexel College of Medicine in Philadelphia. He began seeing patients on Oct. 1, 2020.

Vanderbilt researchers have concluded that children with autism spectrum disorder (ASD) tend to have higher body mass index (BMI) percentiles when compared to youth with typical development.